Teva Pharmaceutical Industries Limited American Depositary Shares

9.05+0.3200+3.67%Vol 11.27M1Y Perf 4.69%
Sep 23rd, 2021 16:00 DELAYED
BID9.01 ASK9.10
Open8.84 Previous Close8.73
Pre-Market- After-Market9.08
 - -  0.03 0.33%
Target Price
11.10 
Analyst Rating
Hold 2.65
Potential %
22.65 
Finscreener Ranking
     32.95
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
     38.61
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
     23.75
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
 —    -
Price Range Ratio 52W %
16.01 
Earnings Rating
Sell
Market Cap9.88B 
Earnings Date
4th Nov 2021
Alpha-0.03 Standard Deviation0.15
Beta1.45 

Today's Price Range

8.749.14

52W Range

8.2413.30

5 Year PE Ratio Range

-6.90547.30

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
0.67%
1 Month
-4.44%
3 Months
-13.15%
6 Months
-19.63%
1 Year
4.69%
3 Years
-62.07%
5 Years
-82.42%
10 Years
-71.73%

TickerPriceChg.Chg.%
TEVA9.050.32003.67
AAPL146.830.98000.67
GOOG2 836.5317.76000.63
MSFT299.560.98000.33
XOM57.081.87003.39
WFC47.800.72001.53
JNJ164.860.93000.57
FB345.962.75000.80
GE102.964.42004.49
JPM161.185.27003.38
Financial StrengthValueIndustryS&P 500US Markets
0.50
1.00
0.68
2.48
-2.40
Leverage Ratio 5.00
ProfitabilityValueIndustryS&P 500US Markets
45.00
-17.10
-8.20
-19.30
-23.77
RevenueValueIndustryS&P 500US Markets
16.32B
14.81
-6.82
-3.07
Earnings HistoryEstimateReportedSurprise %
Q02 20210.550.573.64
Q01 20210.550.609.09
Q04 20200.610.644.92
Q03 20200.560.560.00
Q02 20200.500.524.00
Q01 20200.570.7328.07
Q04 20190.590.613.39
Q03 20190.580.56-3.45
Earnings Per EndEstimateRevision %Trend
9/2021 QR0.63-4.55Negative
12/2021 QR0.68-5.56Negative
12/2021 FY2.51-1.18Negative
12/2022 FY2.63-3.66Negative
Next Report Date4th Nov 2021
Estimated EPS Next Report0.63
Estimates Count3
EPS Growth Next 5 Years %3.70
Volume Overview
Volume11.27M
Shares Outstanding1.09B
Shares Float1.10B
Trades Count31.57K
Dollar Volume135.69M
Avg. Volume8.87M
Avg. Weekly Volume10.23M
Avg. Monthly Volume6.29M
Avg. Quarterly Volume8.75M

Teva Pharmaceutical Industries Limited American Depositary Shares (NYSE: TEVA) stock closed at 9.05 per share at the end of the most recent trading day (a 3.67% change compared to the prior day closing price) with a volume of 11.27M shares and market capitalization of 9.88B. Is a component of indices and it is traded on NYSE exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 40216 people. Teva Pharmaceutical Industries Limited American Depositary Shares CEO is Kare Schultz.

The one-year performance of Teva Pharmaceutical Industries Limited American Depositary Shares stock is 4.69%, while year-to-date (YTD) performance is -6.22%. TEVA stock has a five-year performance of -82.42%. Its 52-week range is between 8.24 and 13.3, which gives TEVA stock a 52-week price range ratio of 16.01%

Teva Pharmaceutical Industries Limited American Depositary Shares currently has a PE ratio of -2.50, a price-to-book (PB) ratio of 0.96, a price-to-sale (PS) ratio of 0.59, a price to cashflow ratio of 21.90, a PEG ratio of 2.32, a ROA of -7.30%, a ROC of -8.55% and a ROE of -31.39%. The company’s profit margin is -23.77%, its EBITDA margin is -8.20%, and its revenue ttm is $16.32 Billion , which makes it $14.81 revenue per share.

Of the last four earnings reports from Teva Pharmaceutical Industries Limited American Depositary Shares, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.63 for the next earnings report. Teva Pharmaceutical Industries Limited American Depositary Shares’s next earnings report date is 04th Nov 2021.

The consensus rating of Wall Street analysts for Teva Pharmaceutical Industries Limited American Depositary Shares is Hold (2.65), with a target price of $11.1, which is +22.65% compared to the current price. The earnings rating for Teva Pharmaceutical Industries Limited American Depositary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Teva Pharmaceutical Industries Limited American Depositary Shares has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Teva Pharmaceutical Industries Limited American Depositary Shares has a Sell technical analysis rating based on Technical Indicators (ADX : 7.99, ATR14 : 0.26, CCI20 : -131.05, Chaikin Money Flow : -0.36, MACD : -0.21, Money Flow Index : 40.06, ROC : -7.91, RSI : 32.32, STOCH (14,3) : 13.21, STOCH RSI : 0.31, UO : 27.87, Williams %R : -86.79), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Teva Pharmaceutical Industries Limited American Depositary Shares in the last 12-months were: Amir Elstein (Option Excercise at a value of $0), Brendan P. O'Grady (Option Excercise at a value of $0), Brendan P. O'Grady (Sold 55 850 shares of value $638 421 ), David Matthew Stark (Option Excercise at a value of $0), David Matthew Stark (Sold 121 052 shares of value $1 407 083 ), Eric Drape (Option Excercise at a value of $0), Eric Drape (Sold 86 045 shares of value $960 020 ), Gerald M. Lieberman (Option Excercise at a value of $0), Gianfranco Nazzi (Option Excercise at a value of $0), Gianfranco Nazzi (Sold 35 970 shares of value $427 357 ), Hafrun Fridriksdottir (Option Excercise at a value of $0), Hafrun Fridriksdottir (Sold 161 035 shares of value $1 740 050 ), Janet S. Vergis (Option Excercise at a value of $0), Jean-Michel Halfon (Option Excercise at a value of $0), Kare Schultz (Option Excercise at a value of $0), Mark Sabag (Option Excercise at a value of $0), Mark Sabag (Sold 127 244 shares of value $1 427 614 ), Nechemia J. Peres (Option Excercise at a value of $0), Perry D. Nisen (Option Excercise at a value of $0), Richard Daniell (Option Excercise at a value of $0), Richard Daniell (Sold 76 928 shares of value $960 713 ), Roberto A. Mignone (Option Excercise at a value of $0), Ronit Satchi-Fainaro (Option Excercise at a value of $0), Rosemary A. Crane (Option Excercise at a value of $0), Sol J. Barer (Option Excercise at a value of $0), Sven Dethlefs (Option Excercise at a value of $0), Sven Dethlefs (Sold 36 275 shares of value $446 587 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
4 (21.05 %)
4 (18.18 %)
4 (18.18 %)
Moderate Buy
1 (5.26 %)
1 (4.55 %)
1 (4.55 %)
Hold
12 (63.16 %)
13 (59.09 %)
13 (59.09 %)
Moderate Sell
1 (5.26 %)
1 (4.55 %)
1 (4.55 %)
Strong Sell
1 (5.26 %)
3 (13.64 %)
3 (13.64 %)
Summary RatingHold
2.65
Hold
2.88
Hold
2.88

Teva Pharmaceutical Industries Limited American Depositary Shares

Teva Pharmaceutical Industries Ltd is the largest generic drug manufacturer in the world with roughly 60 manufacturing and R&D facilities. The company was formed in 1901 and has a portfolio of more than 3,500 medicines--roughly 1 out of 9 generic prescriptions in the U.S. is filled with a Teva product. The company also develops branded pharmaceuticals in the central nervous system, oncology, and respiratory categories. Teva's generic drug sales represent slightly over half of total revenue, with branded drug and distribution revenue making up the balance. Teva is an aggressive filer to bring generic drugs to market when brand patents expire and has the most generic products pending Food and Drug Administration approval.

CEO: Kare Schultz

Telephone: +972 39148213

Address: 5 Basel Street, Petach Tikva 4951033, , IL

Number of employees: 40 216

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

83%17%

Bearish Bullish

55%45%

Bearish Bullish

55%45%

News

Stocktwits